Robert Grubb to Neoplasm Staging
This is a "connection" page, showing publications Robert Grubb has written about Neoplasm Staging.
Connection Strength
0.289
-
Prospective study of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for staging of muscle-invasive bladder carcinoma. J Clin Oncol. 2009 Sep 10; 27(26):4314-20.
Score: 0.067
-
Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer. Cancer Med. 2019 07; 8(8):3698-3709.
Score: 0.033
-
The comparative effectiveness of decision aids in diverse populations with early stage prostate cancer: a study protocol for a cluster-randomized controlled trial in the NCI Community Oncology Research Program (NCORP), Alliance A191402CD. BMC Cancer. 2018 Aug 06; 18(1):788.
Score: 0.031
-
Prostate Magnetic Resonance Imaging Provides Limited Incremental Value Over the Memorial Sloan Kettering Cancer Center Preradical Prostatectomy Nomogram. Urology. 2018 03; 113:119-128.
Score: 0.030
-
Preliminary evaluation of urinary soluble Met as a biomarker for urothelial carcinoma of the bladder. J Transl Med. 2014 Oct 21; 12:199.
Score: 0.024
-
Sex steroid hormone metabolism in relation to risk of aggressive prostate cancer. Cancer Epidemiol Biomarkers Prev. 2014 Nov; 23(11):2374-82.
Score: 0.024
-
Laparoscopic retroperitoneal lymph node dissection for low-stage cancer: a Washington University update. J Endourol. 2011 Nov; 25(11):1753-7.
Score: 0.019
-
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet. 2010 Nov; 42(11):978-84.
Score: 0.018
-
The role of lymphovascular space invasion in renal cell carcinoma as a prognostic marker of survival after curative resection. Urol Oncol. 2011 Nov-Dec; 29(6):738-44.
Score: 0.017
-
Prostate-specific antigen velocity and prostate cancer gleason grade and stage. Cancer. 2007 Apr 15; 109(8):1689-95.
Score: 0.014
-
Delays in cancer detection using 2 and 4-year screening intervals for prostate cancer screening with initial prostate specific antigen less than 2 ng/ml. J Urol. 2005 Apr; 173(4):1116-20.
Score: 0.012